In early Jun. 2019, some female colleagues went toHong Kongto vaccinate HPV 9-valent vaccine. In line with the concept of caring for the physical and mental health of employees, ZONCELL has arranged for some female colleagues to go to Hong Kong to be vaccinated with HPV 9 vaccine since the end of 2018. This is the last injection of these colleagues.

HPV 9-valent vaccine can prevent 90% of cervical cancer, which is the most comprehensive advanced version of the new composite vaccine in the world. It can prevent cervical cancer, vulvar cancer, vaginal cancer, anal cancer, genital warts, persistent infection, precancerous lesions or atypical lesions caused by these viruses. A total of three injections of the vaccine were required, one in 0, 2 and 6 months.

Issued by Miss Zheng, ADD, Jun. 3, 2019.

Prev：2018/5/19 First Invention Patent be Granted

Next：2018/8/14 Three Patents for Utility Models and One Patent for Appearance Design were Obtained